Journal of Hematology and Oncology Research
Ongoing Special Issue
Special Issue On -
Advances in Non-Hodgkin Lymphomas
Special issue By - Zilu Zhu
This special issue calls for original papers with important and novel contributions related to –“
Diffuse Large B-Cell Lymphoma (DLBCL)”
Topics of interests include
- Cancer therapy
- Cancer Care
- Case reports
- Quality of life
- Risk factors
We look for high quality publications on - "Advances in Non-Hodgkin Lymphoma.".
Reviews which include the comparative view, Original research papers as well as short communications and letters on new developments and applications are welcome and are to be written in Standard English. Formatting of manuscript with headings and Sub headings is necessary and views are to be presented clearly. New approaches are mainly in interest.
To cover the costs of publication, an Article Processing Charge is essential and the charge levied for each article of any type upon acceptance is $810 USD.
- Last Date of Submissions: Sep 30, 2019
- Acceptance period:
- 1st round – 1 month
- 2nd round – 3 weeks
- 3rd round – 2 weeks
- 4th round – 1 week
- Last Date of Publication: Nov 30, 2019
- People involved: Dr. Zilu Zhu - Editor
The importance and need for this special issue:
The emerging challenges and solutions provided by Modern methods are extremely interesting and are of great hope for the future. This platform brings forth the outstanding research information in the specified field which helps researchers to have a perfect source specifically designed for research on "Diffuse Large B-Cell Lymphoma (DLBCL)" with much emphasis on immunity and cure
This resource not only affects the way the trending research is evolving, but also creates tremendous new support for the now working researchers to put forth their work at a worthy and specifically targeted readership for the desired proper usage of the knowledge dissipated by you.
This research area has many new challenges in the future and many challenges still remain to be resolved, and we hope that this issue will help to open new horizons for research on Diffuse Large B-Cell Lymphoma (DLBCL)